This post has expired! It was posted more than 90 days ago.
<- Back

137407 - Heart-smart approaches to diabetes management

  • : Online


There continues to be a high degree of interest amongst HCPs on how to optimise glycaemic control for all patients/levels of beta cell function while reducing hypoglycaemia events and cardiovascular risk. Recent clinical evidence suggests that specific medications may have unique properties that may accomplish this unique goal. GPs are becoming more aware of this data but are not necessarily acting upon it. In this module, GPs will review the benefits of individualising diabetes treatment protocols based on patients’ HbA1C, presence of cardiovascular disease and other comorbidities.

Relevance to General Practice

Macrovascular complications are the primary cause of mortality in type 2 diabetes patients, with myocardial infarction and stroke accounting for 80% of deaths. Assessment of cardiovascular risk is therefore a vital part of diabetes care and can be determined either clinically or with an evidence-based tool.

Learning outcomes
  • Recognising the differences between microvascular and macrovascular complications as they relate to glycaemic control.
  • Differentiating between the cardiovascular outcomes associated with newer hypoglycaemic agents and applying this to clinical practice.
  • Individualising diabetes treatment protocols based on patients’ risk profiles and comorbidities.
  • Identifying clinical situations in which certain antihyperglycaemic medications may be contraindicated or require cessation.
  • Delivery
    137407 - Heart-smart approaches to diabetes management
    2 hours
    Start Date
    End Date
    CPD Points
    2 hours
    Contact Phone
    Log in into view this field.